City

Stanford (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Andrei Iagaru (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

18f-fdg (1)

18f-fspg (1)

laboratory biomarker analysis (1)

pharmacological study (1)

talazoparib (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

stage iv mesothelioma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed

B-Cell Neoplasm
+15 more

Stanford, California

Stanford University Medical Center

Dec 11, 2018

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn

Estrogen Receptor Negative
+22 more

Laboratory Biomarker Analysis
+2 more

(no location specified)

Apr 20, 2017